###begin article-title 0
###xml 48 65 48 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trypanosoma Cruzi</italic>
Relevance of the Diversity among Members of the Trypanosoma Cruzi Trans-Sialidase Family Analyzed with Camelids Single-Domain Antibodies
###end article-title 0
###begin p 1
Conceived and designed the experiments: LR MU GP FAG ACF. Performed the experiments: LR MU GP LZ. Analyzed the data: LR MU GP LZ FAG ACF. Wrote the paper: LR MU GP FAG ACF.
###end p 1
###begin p 2
Current address: Immune Epitope Database (IEDB), La Jolla, California, United States of America
###end p 2
###begin p 3
###xml 64 81 64 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trypanosoma cruzi</italic>
###xml 1668 1676 1668 1676 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. cruzi</italic>
###xml 64 81 <span type="species:ncbi:5693">Trypanosoma cruzi</span>
###xml 296 302 <span type="species:ncbi:9844">Llamas</span>
###xml 1299 1304 <span type="species:ncbi:9844">llama</span>
###xml 1668 1676 <span type="species:ncbi:5693">T. cruzi</span>
The sialic acid present in the protective surface mucin coat of Trypanosoma cruzi is added by a membrane anchored trans-sialidase (TcTS), a modified sialidase that is expressed from a large gene family. In this work, we analyzed single domain camelid antibodies produced against trans-sialidase. Llamas were immunized with a recombinant trans-sialidase and inhibitory single-domain antibody fragments were obtained by phage display selection, taking advantage of a screening strategy using an inhibition test instead of the classic binding assay. Four single domain antibodies displaying strong trans-sialidase inhibition activity against the recombinant enzyme were identified. They share the same complementarity-determining region 3 length (17 residues) and have very similar sequences. This result indicates that they likely derived from a unique clone. Probably there is only one structural solution for tight binding inhibitory antibodies against the TcTS used for immunization. To our surprise, this single domain antibody that inhibits the recombinant TcTS, failed to inhibit the enzymatic activity present in parasite extracts. Analysis of individual recombinant trans-sialidases showed that enzymes expressed from different genes were inhibited to different extents (from 8 to 98%) by the llama antibodies. Amino acid changes at key positions are likely to be responsible for the differences in inhibition found among the recombinant enzymes. These results suggest that the presence of a large and diverse trans-sialidase family might be required to prevent the inhibitory response against this essential enzyme and might thus constitute a novel strategy of T. cruzi to evade the host immune system.
###end p 3
###begin title 4
Introduction
###end title 4
###begin p 5
###xml 135 138 135 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Gupta1">[1]</xref>
###xml 296 313 296 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trypanosoma cruzi</italic>
###xml 516 519 516 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Barrett1">[2]</xref>
###xml 636 639 636 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Buscaglia1">[3]</xref>
###xml 756 764 756 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. cruzi</italic>
###xml 839 842 839 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Buscaglia1">[3]</xref>
###xml 987 990 987 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Schenkman1">[4]</xref>
###xml 1041 1044 1041 1044 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Tomlinson1">[5]</xref>
###xml 1160 1168 1160 1168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. cruzi</italic>
###xml 1373 1376 1369 1372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Frasch1">[6]</xref>
###xml 1478 1481 1474 1477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Amaya1">[7]</xref>
###xml 1482 1486 1478 1482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Paris1">[10]</xref>
###xml 1928 1931 1917 1920 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Frasch1">[6]</xref>
###xml 1933 1937 1922 1926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Frasch2">[11]</xref>
###xml 1987 1991 1976 1980 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Buscaglia2">[12]</xref>
###xml 1993 1997 1982 1986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Buscaglia3">[13]</xref>
###xml 2094 2098 2083 2087 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Affranchino1">[14]</xref>
###xml 2100 2104 2089 2093 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Leguizamon1">[15]</xref>
###xml 2361 2365 2350 2354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Cremona1">[16]</xref>
###xml 2367 2371 2356 2360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Schenkman2">[17]</xref>
###xml 2548 2551 2537 2540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Frasch1">[6]</xref>
###xml 2616 2624 2605 2613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. cruzi</italic>
###xml 2818 2822 2807 2811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Mucci1">[18]</xref>
###xml 3336 3340 3325 3329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Todeschini1">[19]</xref>
###xml 3622 3626 3611 3615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Agusti1">[20]</xref>
###xml 3690 3694 3679 3683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Mucci2">[21]</xref>
###xml 281 286 <span type="species:ncbi:9606">human</span>
###xml 296 313 <span type="species:ncbi:5693">Trypanosoma cruzi</span>
###xml 756 764 <span type="species:ncbi:5693">T. cruzi</span>
###xml 1160 1168 <span type="species:ncbi:5693">T. cruzi</span>
###xml 2616 2624 <span type="species:ncbi:5693">T. cruzi</span>
Unicellular eukaryotic pathogens have developed a variety of mechanisms to survive in the multicellular organisms that they parasitize [1]. Some of these mechanisms involve surface/shed molecules required to invade cells from the host and/or to evade the host immune response. The human pathogen Trypanosoma cruzi, the agent of the American endemic Chagas disease, has two essential mechanisms to survive in the mammalian host: an intracellular stage and the presence of a diverse surface membrane coat (reviewed in [2]). This coat is made of mucins that are highly glycosylated proteins expressed from a large gene family (reviewed in [3]). The coordinate expression of a large repertoire of mucins containing variable regions in the mammal stages of the T. cruzi life cycle suggests a possible strategy to delay the host immune response [3]. The mucin sugar moiety contains sialic acid that is implicated in key aspects of parasite-host interactions such as cell adhesion and invasion [4], and resistance to non-specific complement attack [5]. Since trypanosomes are unable to synthesize sialic acid, sialylation of mucins is possible due to the activity of T. cruzi trans-sialidase (TcTS), a modified sialidase that instead of hydrolyze sialic acid, transfer the sugar from host glycoconjugates to alpha-galactoses present in mucins of the parasite surface (reviewed in [6]). The three-dimensional structure and the catalytic mechanism of the enzyme were recently determined [7]-[10]. TcTS has a globular core with two domains connected by a long alpha-helix. The N-terminal domain has a six bladed beta-propeller fold and contains the catalytic site. The C-terminal domain shows a lectin-like topology and has not any activity reported until now. In addition to the globular core of the protein, there is a variable number of C-terminal highly antigenic 12 amino acid repeated motif known as SAPA (shed acute phase antigen) [6], [11]. This motif allows the enzyme to remain in blood [12], [13]. Strong anti-SAPA humoral immune response is observed during the acute phase of Chagas' disease [14], [15]. TcTS is encoded in a large gene family of about 140 members, the protein products differing by about 5% in their primary sequence. Half of the gene family members code for inactive proteins due to a mutation in the active site nucleophile Tyr342 by a His [16], [17]. In addition, there are about 1000 genes that were named "trans-sialidase-like" because they have about 30-80% of identity to trans-sialidase genes but lack enzymatic activity [6]. TcTS is a relevant factor in the infection and pathogenesis of T. cruzi. Recently, it has been demonstrated that TcTS is responsible of inducing transient thymic aplasia via apoptosis. This effect could allow the avoidance of the host immune system by the parasite [18]. Given the essential roles of TcTS in infection and pathogenesis, this enzyme is a good target for the development of alternative chemotherapy agents against the parasite. Nevertheless, small compounds with high inhibitory activity for trans-sialidase are not currently available. A sialidase inhibitor, 2,3-didehydro-2-deoxy-N-acetylneuraminic acid (DANA), an analog to the oxocarbenium transition state of the reaction, is 100-fold less effective toward TcTS (Ki = 10 mM) than to bacterial and viral sialidases [19]. Characterization of alternative acceptor molecules, lactose derivatives, allowed the finding of lactitol. This monosaccharide is a better sialic acid acceptor than conventional substrates like lactose. Lactitol partially prevents parasite sialylation and invasion into host cells [20] and the apoptotic effect of TcTS on cells of the immune system [21].
###end p 5
###begin p 6
###xml 130 138 130 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. cruzi</italic>
###xml 138 142 138 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Leguizamon1">[15]</xref>
###xml 144 148 144 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Leguizamon2">[22]</xref>
###xml 150 154 150 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-PereiraChioccola1">[23]</xref>
###xml 296 300 296 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Leguizamon1">[15]</xref>
###xml 471 475 471 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Leguizamon3">[24]</xref>
###xml 646 650 646 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Tribulatti1">[25]</xref>
###xml 66 74 <span type="species:ncbi:9606">patients</span>
###xml 130 138 <span type="species:ncbi:5693">T. cruzi</span>
###xml 374 382 <span type="species:ncbi:9606">patients</span>
Antibodies able to neutralize TcTS activity are normally found in patients with chronic Chagas' disease and animals infected with T. cruzi[15], [22], [23]. However, the onset of this antibody response is delayed until the end of the acute phase and coincides with a decline in parasitemia levels [15]. Anti-trans-sialidase activity has been detected in the sera of infected patients using a very specific and sensitive assay, named trans-sialidase inhibition assay (TIA) [24]. A monoclonal antibody that neutralizes TcTS activity was recently obtained. Passive transfer of this antibody to infected animals prevents TcTS induced thrombocytopenia [25].
###end p 6
###begin p 7
###xml 608 612 608 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Tribulatti1">[25]</xref>
###xml 614 618 614 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Lauwereys1">[26]</xref>
###xml 750 754 750 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-HamersCasterman1">[27]</xref>
###xml 1230 1234 1218 1222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Lauwereys1">[26]</xref>
###xml 1236 1240 1224 1228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Transue1">[28]</xref>
###xml 1359 1363 1347 1351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Lauwereys1">[26]</xref>
###xml 1365 1369 1353 1357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Transue1">[28]</xref>
###xml 1109 1114 <span type="species:ncbi:9606">human</span>
###xml 1118 1123 <span type="species:ncbi:10090">mouse</span>
Despite the large structural and functional diversity of the mammalian antibody repertoire, conventional antibodies (i.e. heterotetramers of two light chains and two heavy chains) acting as competitive enzyme inhibitors are scarcely found in bibliography. They recognize enzymes (and globular proteins in general) by flat complementary surfaces composed by loops of both the heavy and light variable domains. As the active site of TcTS is located in a deep cleft of the protein, it is difficult to obtain a convex binding surface to reach it by experimental immunizations that elicit conventional antibodies [25], [26]. Camelidae, besides the conventional antibodies, also express heavy-chain antibodies, homodimers that consist of only heavy chains [27]. Their variable region, named VHH, is the smallest natural antigen-binding fragment (approximately16,000 Da), and being just one polypeptide chain it is especially suitable for engineering. In particular, longer complementarity-determining region 3 (CDR3) loops protruding from the binding site and the deviation of CDR conformations from the equivalent human or mouse loop structures, suggest that camelid single domain antibodies might have different strategies of binding [26], [28]. In contrast to the antigen binding fragments of conventional antibodies, VHHs are often potent inhibitors of enzymes [26], [28]. Some long CDR3 loops protruding to the active site of the enzyme are responsible for that inhibition.
###end p 7
###begin p 8
###xml 320 328 320 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. cruzi</italic>
###xml 166 172 <span type="species:ncbi:9844">llamas</span>
###xml 320 328 <span type="species:ncbi:5693">T. cruzi</span>
In this work we show that inhibitory antibodies against trans-sialidase can be obtained by phage display selection of single-domain antibody fragments from immunized llamas. These antibodies inhibited the recombinant TcTS that was used for immunization. However, they were unable to inhibit partially purified TcTS from T. cruzi parasites, which are naturally expressed from different genes. Our results suggest that subtle mutations in members of the TcTS family prevent the complete neutralization of the parasite enzymatic activity.
###end p 8
###begin title 9
Results
###end title 9
###begin title 10
###xml 10 16 <span type="species:ncbi:9844">llamas</span>
Immunized llamas show polyclonal inhibitory response against TcTS activity in sera
###end title 10
###begin p 11
###xml 387 391 383 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Pitcovsky1">[29]</xref>
###xml 393 397 389 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Pitcovsky2">[30]</xref>
###xml 543 547 539 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Buschiazzo3">[31]</xref>
###xml 908 916 904 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003524-g001">Figure 1</xref>
###xml 4 10 <span type="species:ncbi:9844">llamas</span>
###xml 74 79 <span type="species:ncbi:9844">Llama</span>
###xml 361 366 <span type="species:ncbi:10090">mouse</span>
###xml 425 430 <span type="species:ncbi:9844">llama</span>
###xml 549 554 <span type="species:ncbi:9844">Llama</span>
###xml 623 628 <span type="species:ncbi:9844">llama</span>
###xml 722 727 <span type="species:ncbi:9844">llama</span>
###xml 1100 1106 <span type="species:ncbi:9844">llamas</span>
Two llamas were immunized using different recombinant TcTS constructions. Llama 7006, was immunized with pTcTSDelta1443 (lacking the 1443 epitope and retaining the SAPA repeats). This recombinant protein was used since deletion of the internal epitope between amino acids 433 and 447, called epitope 1443, increases the production of neutralizing antibodies in mouse models of infection [29], [30]. The second camelid, named llama 9210, was immunized with protein from the clone pTrcTS611/2 (entire globular core of TcTS without SAPA repeats) [31]. Llama 9210 showed a late TcTS inhibitory response and at lower level than llama 7006 (data not shown). Due to the high polyclonal inhibitory response detected in serum from llama 7006 after the fourth immunization, we engaged in the construction of a VHH library from the RNA of lymphocytes isolated from this animal fifteen days after the last immunization (Figure 1). The absence of 1443 epitope and/or the presence of SAPA repeats that increase the half-life in blood could be responsible for the difference in the inhibitory response between both llamas.
###end p 11
###begin title 12
###xml 31 36 <span type="species:ncbi:9844">llama</span>
Inhibition of TcTS activity by llama 7006 serum.
###end title 12
###begin p 13
###xml 130 151 126 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
Serial dilutions of pre-immune and post-recombinant TcTSDelta1443-SAPA immunization sera, were analyzed by TIA as indicated under Materials and Methods.
###end p 13
###begin title 14
Screening for inhibitory clones
###end title 14
###begin p 15
###xml 44 45 44 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 174 183 174 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003524-g002">Figure 2A</xref>
###xml 316 337 316 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 579 588 579 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003524-g003">Figure 3A</xref>
###xml 686 693 686 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003524-t001">Table 1</xref>
###xml 1022 1031 1022 1031 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003524-g002">Figure 2B</xref>
The quality of the library, composed by 2x106 single clones, was checked by sequencing fourteen randomly chosen clones, which showed high variability in nucleotide sequence (Figure 2A). Ninety-four phage-VHH clones obtained from the first round of panning were analyzed by TIA (trans-sialidase inhibition assay, see Materials and Methods) using TcTS611/2. This preliminary TcTS inhibition screening allowed us to identify three clearly defined groups of VHHs: non-inhibitors (NI), weak inhibitors (WI) and strong inhibitors (SI) represented by 74, 13 and 7 clones, respectively (Figure 3A). Since the total percentage of inhibitors (21%) is smaller than the percentage of binders (71%, Table 1), the use of a screening inhibition assay resulted in a powerful strategy to select phage-VHH for inhibitory clones. This result was reproducible when testing soluble VHHs (results not shown). After sequencing, the seven strong TcTS inhibitor clones showed to correspond to four unique clones (clones SI14, SI52, SI57 and SI96, Figure 2B). Selected weak inhibitor clones WI58 and WI48 (a conventional IgG VH) were included for further comparison.
###end p 15
###begin p 16
###xml 4 91 4 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Alignment of the sequences of 14 randomly chosen clones from the library before panning</italic>
###xml 136 191 136 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sequence analysis of the six post-panning selected VHHs</italic>
###xml 537 541 537 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Lefranc1">[46]</xref>
(A) Alignment of the sequences of 14 randomly chosen clones from the library before panning (pre-panning clones are labeled pp) and (B) Sequence analysis of the six post-panning selected VHHs.The 4 strong inhibitors (SI) clones are shown in clear gray background. Lengths in CDR3 are shown in dark gray background. Clone WI48 is a conventional IgG (*) and its characteristic residues are marked in black. Spaces denote identical residues and dashes denote deletions. Numbering and CDR designations are according to IMGT numbering system [46].
###end p 16
###begin p 17
###xml 4 28 4 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Screening of VHH library</italic>
###xml 314 361 314 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Purified VHHs inhibit recombinant TcTS activity</italic>
###xml 601 652 601 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">The selected VHHs recognize conformational epitopes</italic>
###xml 1030 1036 <span type="species:ncbi:9986">rabbit</span>
###xml 1083 1088 <span type="species:ncbi:10090">mouse</span>
(A) Screening of VHH library. 94 individual phages-VHH clones were tested by TIA using TcTS611/2. Three clear groups are observed, NI: non-inhibitors, WI: weak inhibitors, SI: strong inhibitors. Each point represents phages prepared from a single colony. TIA values lower than 25% were considered as negative. (B) Purified VHHs inhibit recombinant TcTS activity. A fixed mass of 0.5 ng of purified TcTS611/2 was preincubated with increasing concentrations of each VHH and trans-sialidase activity was analyzed by TIA. The values represent the average of at least three independent determinations. (C) The selected VHHs recognize conformational epitopes. Recombinant proteins, all carrying a His-tag, were spotted onto nitrocellulose membrane as indicated in the panel 4: A) SI14, B) WI58, C) SI52, D) SI96, E) SI57, F) TcTS611/2, G) Denatured TcTS611/2 in 0.1% SDS, H) Non-related (non-anti-TcTS) VHH. Panel 1 and panel 2 were incubated with native TcTS and denatured TcTS in 0.1% SDS, respectively. Both panels were treated with rabbit anti-TcTS serum. Panel 3 was processed with a mouse anti-Histidine antibody as a control for protein immobilization. Filters were revealed with the corresponding HRP-conjugated-anti-serum for chemiluminescence generation.
###end p 17
###begin title 18
Panning of the library and its evaluation by phage-ELISA.
###end title 18
###begin p 19
SBO: specific binding output.
###end p 19
###begin p 20
NSBO: Non-specific binding output
###end p 20
###begin p 21
Numbers are expressed as colony forming units.
###end p 21
###begin p 22
###xml 12 20 12 20 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003524-g002">figure 2</xref>
As shown in figure 2, none of the SI selected clones appear among the sequenced prepanning clones (except for prepanning clone 16), indicating that their selection was not due to overrepresentation in the library. Besides, prepanning clones showed a higher diversity in sequence and in the CDRs length than inhibitory selected clones. Particularly, CDR3 of prepanning clones range from 9 to 20 amino acids, meanwhile SI clones share the same CDR3 length (17 residues). A common characteristic of VHHs is the presence of long CDR3 loops, which confer increase diversity to the binding site of these single domain antibodies. Clones displaying strong inhibition capacity had very similar sequences, showing that they derived, likely, from the same original clone that had undergone different somatic mutations that affect a pair of CDR residues and framework region 3. In contrast, clones WI48 and WI58, which had low inhibition capacity, had different CDR3 sequence and length, indicating that derived from different clones.
###end p 22
###begin title 23
###xml 14 19 <span type="species:ncbi:9844">llama</span>
Single domain llama antibodies that inhibit recombinant TcTS activity recognize a conformational epitope with affinities in the nanomolar range
###end title 23
###begin p 24
###xml 0 9 0 9 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003524-g003">Figure 3B</xref>
###xml 282 289 282 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003524-t002">Table 2</xref>
###xml 362 363 362 363 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</sub>
###xml 871 880 871 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003524-g003">Figure 3C</xref>
Figure 3B shows the inhibitory activity displayed by soluble purified VHHs against recombinant TcTS611/2. Clone SI14 showed the strongest inhibition activity while clone WI58 showed lower TcTS inhibition activity. We measured the affinities of VHH-TcTS complexes using a biosensor (Table 2). The four selected SI clones showed similar affinities for TcTS, with KD values in the high nanomolar range (22 to 86 nM). Thus, there is a correlation between affinity and inhibition capacity among VHHs since clone SI14, which showed the higher affinity to TcTS on biosensor analysis has the higher inhibition capacity. To analyze whether inhibitory VHH recognize conformational or linear epitopes, purified VHHs spotted onto a nitrocellulose membrane were reacted with native and denatured recombinant TcTS611/2. All VHHs bound native TcTS but did not recognize denatured TcTS (Figure 3C) indicating that the selected inhibitory VHHs recognize discontinuous TcTS epitopes.
###end p 24
###begin title 25
Affinities of TcTS-VHH complexes (IAsys biosensor analysis).
###end title 25
###begin p 26
###xml 5 6 5 6 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</sub>
###xml 36 39 36 39 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">off</sub>
###xml 41 43 41 43 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">on</sub>
The KD value was determined as the Koff/Kon ratio.
###end p 26
###begin title 27
Strong inhibitor VHHs recognize an epitope overlapped to the active site
###end title 27
###begin p 28
###xml 171 174 171 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Buschiazzo2">[9]</xref>
###xml 176 180 176 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Paris1">[10]</xref>
###xml 182 186 182 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Paris2">[32]</xref>
###xml 381 388 381 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003524-t002">Table 2</xref>
Tyr119 and Trp312 are key residues for the activity of the enzyme since proteins mutant TcTS Tyr119Ser and Trp312Ala loose 90% and 100% of transfer activity, respectively [9], [10], [32]. We measured the binding affinity of VHHs to mutant TcTSTrp312Ala and TcTSTyr119Ser. VHHSI14 binds to both mutants with approximately ten times lower affinity compared to recombinant TcTS611/2 (Table 2), indicating that VHHSI14 recognizes residues near or in the active site of TcTS.
###end p 28
###begin p 29
###xml 283 286 283 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Buschiazzo1">[8]</xref>
###xml 288 292 288 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Amaya2">[33]</xref>
###xml 530 539 530 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003524-g004">Figure 4A</xref>
###xml 733 742 733 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003524-g004">Figure 4B</xref>
###xml 1213 1217 1213 1217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Rastam1">[34]</xref>
###xml 306 311 <span type="species:ncbi:9844">llama</span>
###xml 1412 1417 <span type="species:ncbi:9844">llama</span>
The decrease in the binding affinity of VHHSI14 to mutant TcTS prompted us to test the effect of the conformational change of Tyr119. Upon binding of DANA to TcTS active site, residue Tyr119 moves away from catalytic center and it is positioned in front of the indole ring of Trp312 [8], [33]. To study if llama inhibitory single domain antibodies sense the TcTS conformational change produced by DANA, we analyzed the binding kinetics and the response at the equilibrium in the presence or the absence of this ligand. As seen in Figure 4A, the signal obtained upon TcTS611/2 binding increased in the presence of DANA. This increment in the signal is similar to the effect of increasing ten times the concentration of TcTS. As shown Figure 4B, there is a linear correlation between the increase in VHHSI14-TcTS binding response and the DANA concentration. This effect was similarly observed in all the four SI VHHs selected clones (data not shown). This result implies a higher affinity of the SI clones for the conformation adopted by the enzyme upon binding of DANA, which would then enhance the SI VHHs competitive inhibition activity. Interestingly that sialic acid is present at high concentrations in blood [34], thus it is possible that the immune system recognize TcTS in this particular acceptor-bound conformation. In summary, we obtained different results suggesting that this family of single domain llama antibodies recognize with high affinity an epitope close or overlapped to the active site of the enzyme.
###end p 29
###begin title 30
DANA increased the VHH binding to recombinant TcTS.
###end title 30
###begin p 31
Soluble TcTS611/2 was added in the presence or the absence of DANA to a cuvette derivatized with VHH. (A) Binding kinetics of VHHSI96 to TcTS in the presence or absence of 10 mM DANA. (B) Response at the equilibrium of VHHSI14-TcTS in different concentrations of DANA. The addition of DANA did not affect the baseline.
###end p 31
###begin p 32
###xml 87 95 87 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003524-g005">Figure 5</xref>
###xml 143 159 143 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003524-g005">Figure 5A and 5B</xref>
###xml 242 245 242 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Buschiazzo1">[8]</xref>
###xml 247 251 247 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Amaya2">[33]</xref>
Epitope mapping analysis of the binding of the SI VHHs to recombinant TcTS is shown in Figure 5. Comparing free TcTS and DANA-TcTS structures (Figure 5A and 5B), it can be seen that Tyr119 suffers a conformational change upon binding to DANA [8], [33].
###end p 32
###begin title 33
###xml 37 42 <span type="species:ncbi:9844">llama</span>
The epitope recognized by inhibitory llama antibodies maps to the TcTS catalytic site.
###end title 33
###begin p 34
View of the TcTS active site shown as surface representation using the program Chimera. (A) Free TcTS, (B) DANA-TcTS (shows the conformational change upon binding of DANA to TcTS) and (C) shows a 90degrees rotation of TcTS-DANA structure highlighting the arginine 311 residue protruding from the active site. PDBs used are 1MS4 and 1MS8. Residues involved in the catalytic site are colored as follows: mutated residues that were analyzed in this work (Trp312 and Tyr119) in red, other catalytic amino acids (Arg35, Asp59, Asp96, Met98, Arg314, Arg245, Glu230 and Tyr342) in yellow, space-fill model of DANA in green and Arg311 in blue.
###end p 34
###begin title 35
Single domain antibodies fail to inhibit the natural trans-sialidase
###end title 35
###begin p 36
###xml 53 61 53 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. cruzi</italic>
###xml 341 350 341 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003524-g006">figure 6A</xref>
###xml 483 490 483 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003524-t003">Table 3</xref>
###xml 656 663 656 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003524-t003">Table 3</xref>
###xml 1089 1101 1089 1101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brucella spp</italic>
###xml 1121 1125 1121 1125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Craig1">[35]</xref>
###xml 1492 1499 1492 1499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003524-t003">Table 3</xref>
###xml 53 61 <span type="species:ncbi:5693">T. cruzi</span>
VHHSI14 was tested against supernatants of Cl-Brener T. cruzi-infected cell cultures containing TcTS released from the trypomastigote stage of the parasite. Surprisingly, VHHSI14 failed to inhibit the enzyme present in parasite supernatants while a strong inhibition activity toward the recombinant TcTS611/2 used as a control was observed (figure 6A). Supernatants from three different strains were assayed in the presence of an excess of VHHSI14 antibody, showing similar results (Table 3). The lack of inhibition by VHHSI14 antibody was not due to the presence of any compound in the medium since recombinant TcTS added in the reaction was neutralized (Table 3). Similar negative results were observed with live Cl-Brener trypomastigotes containing TcTS linked to the membrane surface of the parasites (data not shown). To analyze if the ausence of inhibition was due to the univalent nature of VHHs, we increased the avidity of this antibody fragment. To this end, we constructed a fusion protein displaying ten VHH domains per assembly, taking advantage of the decameric structure of Brucella spp. lumazine synthase [35]. This assembly allowed to increase 10 times the avidity of VHHSI14 for recombinant TcTS but did not show differences in its inhibitory capacity as compared with that of the monomeric VHHSI14 (data not shown). This construction was assayed against Cl-Brener trypomastigotes and it was still unable to inhibit the activity of TcTS present in the surface of parasites (Table 3).
###end p 36
###begin p 37
###xml 4 46 4 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Natural TcTS was not inhibited by VHHSI14.</italic>
###xml 139 148 139 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. cruzi-</italic>
###xml 322 397 322 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Independent recombinant TcTSs are inhibited to different extents by VHHSI14</italic>
###xml 455 463 455 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. cruzi</italic>
###xml 139 147 <span type="species:ncbi:5693">T. cruzi</span>
###xml 455 463 <span type="species:ncbi:5693">T. cruzi</span>
(A) Natural TcTS was not inhibited by VHHSI14. Comparison of VHH114 inhibition activity of the TcTS present in supernatants from Cl-Brener T. cruzi-infected cell cultures versus a recombinant TcTS611/2 enzyme. The decameric form of VHHSI14 was used. The values represent the average of two independent determinations. (B) Independent recombinant TcTSs are inhibited to different extents by VHHSI14. A fixed mass of 0.5 ng of different purified TcTSs from T. cruzi were preincubated with increasing concentrations of VHHSI14 decameric form and the remaining trans-sialidase activity was analyzed by TIA. The values represent the average of at least three independent determinations.
###end p 37
###begin title 38
###xml 39 47 <span type="species:ncbi:5693">T. cruzi</span>
Effect of VHHSI14 on natural TcTS from T. cruzi trypomastigotes.
###end title 38
###begin p 39
Results are expressed in CPM (Counts Per Minute) obtained after 1 hour of reaction (by TIA). The values are the mean and standard deviation of at least three independent experiments.
###end p 39
###begin p 40
Lactitol was assayed as positive inhibition control on Natural TcTS.
###end p 40
###begin p 41
Recombinant TcTS was assayed as positive control of inhibition in every single test.
###end p 41
###begin p 42
Parenthesis indicate percentage of inhibition of TcTS activity that remnant CPM represents .
###end p 42
###begin p 43
Supernatant from cell culture derived trypomastigotes were used.
###end p 43
###begin p 44
ND: not determinated.
###end p 44
###begin p 45
Decameric form of VHHS14 was used.
###end p 45
###begin title 46
The lack of inhibition of the natural trans-sialidase is due to differences among members of the enzyme family
###end title 46
###begin p 47
###xml 172 179 172 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 378 387 378 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003524.s003">figure S2</xref>
###xml 458 477 458 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trypanosoma rangeli</italic>
###xml 488 491 488 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Buschiazzo1">[8]</xref>
###xml 493 496 493 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Buschiazzo2">[9]</xref>
###xml 816 825 816 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003524.s002">figure S1</xref>
###xml 950 957 950 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003524-t003">Table 3</xref>
###xml 172 179 <span type="species:ncbi:562">E. coli</span>
###xml 458 477 <span type="species:ncbi:5698">Trypanosoma rangeli</span>
A possible explanation for this contradictory result could be the existence of post-translational modifications present in the natural enzyme but absent in the recombinant E. coli TcTS enzymes. It is known that natural TcTS is glycosylated. One of the two possible N-glycosylation sites, located in residue 114, is close to the active site (predicted by NetNgly 1.0 server, see figure S2) and it corresponds with a N-glycosylation observed in residue 115 of Trypanosoma rangeli sialidase [8], [9]. No VHHSI14 inhibitory activity was seen when natural TcTS was immunoprecipitated from extracts of Cl-Brener trypomastigotes (the infective form of the parasite in the mammalian host) using an anti-SAPA antibody and treated with the high processive enzyme PNGase F. Controls of the deglycosylation process are shown in figure S1. Thus, it is unlikely that the presence of sugars in the natural TcTS were the reason of the lack of inhibition by VHHSI14 (Table 3).
###end p 47
###begin p 48
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. cruzi</italic>
###xml 129 133 129 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Cremona1">[16]</xref>
###xml 427 436 427 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003524.s003">Figure S2</xref>
###xml 535 556 535 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 559 568 559 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003524-g006">Figure 6B</xref>
###xml 1070 1078 1070 1078 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003524.s001">Table S1</xref>
###xml 1384 1391 1384 1391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003524-t004">Table 4</xref>
###xml 0 8 <span type="species:ncbi:5693">T. cruzi</span>
T. cruzi is known to have a large number of TcTS genes, 70 in a strain of the parasite, expressing enzymatically active proteins [16]. It is also known that these genes somewhat differ in their primary sequence. These differences might cause the variations in the inhibitory effects of antibodies on the TcTS family. To test this hypothesis, we cloned and expressed five active recombinant TcTS clones by PCR (see sequences in Figure S2, supplemental data) using specific primers to amplify the entire globular core of the enzyme (see Materials and Methods). Figure 6B resume results of VHHSI14 decameric form tested toward these recombinant TcTSs clones using TIA assay. The five clones plus the TcTS611/2, used as a control, were inhibited to different extents by the VHHSI14 when they were tested under the same experimental conditions. TcTS-46 and TcTS-49 were poorly inhibited when increasing amounts of VHHSI14 were added. Both clones have several changes in their primary sequence as deduced from DNA sequencing (90.3 and 90.6% of identity respect TcTS611/2, see Table S1 in supplemental data). TcTS-24 was highly inhibited, even more than TcTS611/2, the clone whose product was used for the immunization, while TcTS-12 and TcTS-15 present intermediate inhibitory levels. Similar results were obtained when an excess of the other strong inhibitors VHHs were tested with TcTSs (Table 4). These results suggest that the VHHs antibody fragments might recognize minor antigenic differences between natural TcTSs resulting in different inhibition levels.
###end p 48
###begin title 49
Effect of 200 ng of each strong inhibitor VHH on different TcTS clones from Cl-Brener strain.
###end title 49
###begin p 50
###xml 92 94 92 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 98 100 98 100 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
Trans-sialidase activity was expressed in nmoles of syalil residue transferred to lactosexmg-1xmin-1 (by TIA). The values are the mean and standard deviation of at least three independent experiments.
###end p 50
###begin p 51
Parenthesis indicate percentage of inhibition of TcTS activity that the remnant activity represents.
###end p 51
###begin p 52
Lactitol was used was assayed as positive control of inhibition of TcTS activity.
###end p 52
###begin p 53
###xml 290 299 290 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003524-g005">Figure 5C</xref>
###xml 660 667 660 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003524-t002">Table 2</xref>
###xml 880 885 <span type="species:ncbi:9844">llama</span>
Next we analyzed the identity of the amino acid residues in the active site among all TcTS clones tested. All TcTSs that were inhibited by the camelid antibody have an arginine at position 311, which protrudes from the active site (as is shown in the wild-type TcTS-DANA complex structure, Figure 5C). In contrast, both TcTS that were almost not inhibited by VHHSI14 (TcTS-46 and TcTS-49) have a tryptophan residue in position 311 instead of arginine. We postulate that this bulky tryptophan, among other differences, might interfere with the binding to antibodies. Since we found that two mutations at single amino acid positions strongly affect VHH binding (Table 2), these results are in agreement with the possibility that differences in amino acid residues located close to, or in, the active site might result in the lack or decreased inhibition of some TcTS members by the llama antibodies.
###end p 53
###begin title 54
Discussion
###end title 54
###begin p 55
###xml 60 65 <span type="species:ncbi:9844">llama</span>
###xml 389 395 <span type="species:ncbi:9844">llamas</span>
In this work, we report the identification of single domain llama antibodies against recombinant TcTS that bind a site close or overlapping the active site of the enzyme. The antibodies had the expected inhibitory capacities and affinities and were obtained after one round of phage display selection. Three key factors allowed the success of the strategy used. First, the immunization of llamas allowed us to obtain the smallest antibody fragments with usually protruding long loops that facilitate the access to the active site cleft of enzymes. Second, the use of engineered TcTS, as immunogen, that increased the probabilities of raising antibodies that recognize the enzyme active site. Third, the use of a strategy that is based on a soluble inhibition screening test, instead of the classic binding assay to select a phage display library. Clones showing strong inhibitory activities represent approximately 7% of the selected clones, which is a logical result taking into account that TcTS is a large protein (70,000 Da). Thus, a sensitive phage-TIA assay allowed us for a simple, fast and very efficient selection of clones with inhibitory capacity. All seven selected clones represent four different single domain antibodies derived from the same clone, as can clearly be seen for their high sequence homology and an identical VDJ recombination sites. The consensus sequence contains a 17 residues long CDR3, with just one conservative difference at position 115 (Valine to Isoleucine). Thus, these results suggest that in our library there is only one structural solution for obtaining antibodies tightly binding to the recombinant TcTS active site used as immunogen.
###end p 55
###begin p 56
###xml 95 99 95 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Harmsen1">[36]</xref>
###xml 170 174 170 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Lauwereys1">[26]</xref>
###xml 176 180 176 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Harmsen1">[36]</xref>
###xml 181 185 181 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Desmyter1">[38]</xref>
VHHs described in the literature recognize globular proteins with affinities between 20-100 nM [36]. Particularly, camelid fragments with enzymatic inhibitory capacities [26], [36]-[38] have affinities in the 25+/-21 nM range, showed similar CDR1 and CDR2 length (8+/-1.5 and 7.7+/-0.7 residues, respectively) and differ in the number of disulfide bonds and in the CDR3 length from 11 to 24 residues, resulting in an average of 15.8+/-3.6 residues. Thus, our four selected clones fall within the range of the previously described inhibitory single domain antibodies since they showed affinities in the 22-86 nM range and have CDR lengths of 8, 7 and 17 residues for CDR1, CDR2, and CDR3, respectively. As the four selected VHHs derive from the same clone, thus it is fair to assume that all of them bind to the same epitope on TcTS. In coincidence, there is a clear correlation between affinity and inhibitory capacity among these four clones, being clone SI14 the one that shows the higher affinity and also the stronger inhibition capacity.
###end p 56
###begin p 57
###xml 198 205 198 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003524-t002">Table 2</xref>
###xml 268 276 268 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003524-g004">Figure 4</xref>
Site directed mutagenesis of TcTS Tyr119 and Trp312 residues, which are implicated in the enzymatic mechanism of trans-sialidase activity, decreases about ten times their binding to the antibodies (Table 2), while the addition of DANA increases their binding to TcTS (Figure 4). It can be inferred that these antibodies recognize this surface on the catalytic site. Whether the longer CDR3 loops of these antibodies penetrate inside the cavity or, alternatively, the binding of the VHHs does not allow the access of the acceptor lactose, remains to be demonstrated.
###end p 57
###begin p 58
###xml 755 762 755 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003524.s002">Fig. S1</xref>
###xml 89 94 <span type="species:ncbi:9844">llama</span>
Despite we observed a strong inhibition of the recombinant TcTS used for immunization by llama single domain antibodies; they were unable to inhibit the complex mixture of TcTSs expressed in trypomastigote parasites. Purified VHHs inhibited recombinant TcTS611/2 by 60-80% and VHHS114 inhibited 8-98% the enzymatic activity of different recombinant trans-sialidases. On the other hand, the natural enzyme from Cl-Brener strain was inhibited only between 3% and 12%. There are several possible explanations for these apparently contradictory findings. One is that glycosylation of the natural enzyme, not present in the enzyme expressed in bacterial systems, might prevent the interaction of the enzyme with the VHH. This does not seem to be the case (see Fig. S1). However, we can not completely exclude the possibility that PNGase failed to fully deglycosylate all of the different natural TS enzymes. Even if this was the case, these results do not invalidate those showing that different recombinant enzymes expressed in bacterial systems are inhibited to different extents by VHHs, one of the main conclusions of this work. An alternative explanation is the presence of TcTS-like molecules lowering the effective concentration of VHHs or the presence of other inhibitors in the natural enzyme sample. A recombinant TcTS added to the natural enzyme sample was inhibited, precluding the previously mentioned possibility. Clearly, it is not possible at present to find a simple explanation for the above mention findings, which awaits results from a different approach, like structural studies, to solve it.
###end p 58
###begin p 59
###xml 390 394 390 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Atwood1">[39]</xref>
###xml 1221 1225 1221 1225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Atwood1">[39]</xref>
The results obtained in this work, showing that different recombinant TcTS protein products are inhibited to different extents by the four VHHs tested, indicate that VHHs could recognize minor antigenic differences present in the polymorphic population of natural trans-sialidases, as this enzymatic activity potentially derives from the simultaneous expression of about 70 different genes [39]. These observations suggest an interesting hypothesis to explain the possible usefulness for the presence of a TcTS family. If trans-sialidase activity results from the expression of a single gene, one antibody clone might be enough to completely neutralize the enzymatic activity. The simultaneous expression of a large number of trans-sialidases slightly differing in primary sequence but not in enzymatic activity might delay the complete inhibition of the parasite enzyme. In addition to genes encoding trans-sialidase enzymes, there is a larger number of trans-sialidase genes (about 1000), coding for proteins with homologies to trans-sialidase but lacking enzymatic activity. These non-enzymatic proteins might be further involved in the distraction of the immune antibody response against active members of the family [39]. In summary, a large part of the genome is devoted to encode trans-sialidase and trans-sialidase-like proteins likely to be involved in the protection against a neutralizing activity that might prevent parasite development in the mammalian host.
###end p 59
###begin p 60
###xml 80 85 <span type="species:ncbi:9844">llama</span>
Presently, we do not know which TcTS amino acid positions are recognized by the llama antibody VHHSI14 to neutralize enzymatic activity. Future work, including the determination of TcTS structure in complex with antibodies will indicate if there are mutational hot-spots for the generation of TcTS diversity preventing interaction with antibodies but not affecting the enzymatic activity. However, structural and bioinformatic analyses allowed us to identify a key role of residue 311. Arg311 side chain protrudes in the active site while both poorly inhibited TcTS (TcTS-46 and TcTS-49) have a bulky tryptophan at this position. Thus, we postulate that Trp311 would be responsible for steric hindrance of the VHH binding to the epitope recognized in the enzyme.
###end p 60
###begin p 61
###xml 189 192 189 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Buscaglia1">[3]</xref>
###xml 318 326 318 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. cruzi</italic>
###xml 724 732 724 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. cruzi</italic>
###xml 732 736 732 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Leguizamon1">[15]</xref>
###xml 738 742 738 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Leguizamon3">[24]</xref>
###xml 801 805 801 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Mucci2">[21]</xref>
###xml 807 811 807 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Tribulatti1">[25]</xref>
###xml 813 817 813 817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Fontanella1">[40]</xref>
###xml 818 822 818 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Vasconcelos1">[43]</xref>
###xml 318 326 <span type="species:ncbi:5693">T. cruzi</span>
###xml 724 732 <span type="species:ncbi:5693">T. cruzi</span>
We have previously postulated that the amplification and divergence of the members of the mucin family covering the trypanosomal surface are also involved in delay the host immune response [3]. In this case, coordinate expression of a large repertoire of mucins containing variable regions in the mammal stages of the T. cruzi life cycle might delay a lytic antibody response. In the case of TcTS, coordinate expression of several enzymatically active proteins having subtle differences at amino acid positions in or around the active site might delay the immune response inhibiting the complete enzymatic makeup of the parasite. Antibodies neutralizing TcTS are detectable in the host serum later during the infection with T. cruzi[15], [24], and through immunization with recombinant enzymes or DNA [21], [25], [40]-[43]. Thus, our model of epitope variation among TcTS members to prevent an inhibitory response might apply for the early stages of the infection, period during which the parasite requires the necessary time to reach the niches inside the host cells.
###end p 61
###begin title 62
Materials and Methods
###end title 62
###begin title 63

###end title 63
###begin title 64
TcTS expression and purification
###end title 64
###begin p 65
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 181 186 181 186 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">600nm</sub>
###xml 0 7 <span type="species:ncbi:562">E. coli</span>
E. coli strain BL21 (DE3) pLysS (Novagen) was transformed with plasmids (pTrcHisA, Invitrogen) encoding different TcTS clones. A dilution of the over night culture was grown until A600nm 1.0-1.2 in constant agitation at 37degreesC. To over express TcTS, 0.5 mM isopropyl-beta-D-thiogalactopyranoside (IPTG, Sigma) was added and growth was continued with constant agitation at 18degreesC, for 12-16 hs. Harvested cells were conserved at -80degreesC until purification. Bacterial cells were resuspend in 20 mM Tris-HCl pH 8.0, 0.5 M NaCl, 0.5% triton, 100 microg/ml DNase I, 1 mM phenylmethanesulfonyl fluoride (Sigma) and sonicated several times to reduce viscosity in a Brandson 450 sonicator. Supernatant was ultracentrifugated (45000 rpm, 45 min in a 70Ti rotor), filtered through 0.22 microm membrane filter and subjected to a Ni++ charged Hi-Trap chelating HP column (Amersham Pharmacia Biotech). Column was washed with 30 mM imidazole (Sigma) and elution was done using 100 mM imidazole in 20 mM Tris-HCl pH 8.0, 0.5 M NaCl. Elution peak was dialyzed against Tris-HCl pH 8.8, 30 mM NaCl, 1 mM EDTA and further purified by FPLC anionic exchange (MonoQ, Amersham Pharmacia Biotech). Elution was done applying a linear gradient of NaCl.
###end p 65
###begin title 66
Immunization
###end title 66
###begin p 67
###xml 19 29 19 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lama glama</italic>
###xml 11 17 <span type="species:ncbi:9844">llamas</span>
###xml 19 29 <span type="species:ncbi:9844">Lama glama</span>
Young male llamas (Lama glama) were injected at days 0, 21, 35 and 56 with 0.5 mg of recombinant TcTSs, using aluminum hydroxide as adjuvant. Before each boost, blood samples were collected and the sera were used to ascertain the immune response from the last immunization. At day 62 anticoagulated blood was collected and used for mononuclear cell isolation. All animal procedures were approved by the animal care committee of the IIB-INTECH in accordance with the guidelines laid out by the NIH regarding the care and use of animals for research.
###end p 67
###begin title 68
Construction of the library
###end title 68
###begin p 69
###xml 267 269 259 261 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">30</sub>
###xml 37 42 <span type="species:ncbi:9844">llama</span>
Mononuclear cells were isolated from llama 7006 heparinized blood by Ficoll-Hypaque (Pharmacia) gradient centrifugation. Total RNA was purified by TRIZOL reagent (Pharmacia) and subject to cDNA synthesis. To synthesize cDNA, 3 microg of RNA and 1.5 microg of oligo-dT30 in 7.5 microl were incubated for 10 min at 70degreesC and placed on ice. After a spin down, 0.4 mM dNTPs, RT buffer 1X, 200U M-MLV RT (Promega) and 25U RNAsin (Promega) were added, in a total volume of 25 microl and incubated 1 h at 42degreesC. The reaction was stopped at 70degreesC for 15 min.
###end p 69
###begin p 70
###xml 369 373 369 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Muyldermans1">[44]</xref>
###xml 436 454 436 454 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G GCC CAG CCG GCC </underline>
###xml 410 492 410 492 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GCT GGA TTG TTA TTA CTC GC<underline>G GCC CAG CCG GCC </underline>ATG GCC CAG GTS MAR CTG CAG SAG TCW GG</named-content>
###xml 534 552 534 552 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G GCC CAG CCG GCC </underline>
###xml 508 598 508 598 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GCT GGA TTG TTA TTA TCT GC<underline>G GCC CAG CCG GCC </underline>ATG GCC GAT GTG CAG CTG CAG GCG TCT GGR GGA GG</named-content>
###xml 635 646 635 646 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GC GGC CGC </underline>
###xml 609 676 609 676 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">I: G ATG GTG ATG ATG ATG T<underline>GC GGC CGC </underline>GCT GGG GTC TTC GCT GTG GTG CG</named-content>
###xml 713 724 713 724 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GC GGC CGC </underline>
###xml 690 755 690 755 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">G ATG GTG ATG ATG ATG T<underline>GC GGC CGC </underline>TGG TTG TGG TTT TGG TGT CTT GGG</named-content>
cDNAs encoding an entire VHH domain and part of the hinge region were amplified by PCR using primers VH1Back-SfiI or VH6Back-SfiI in combination with primer Lamb7-NotI or Lamb8-NotI. Primer VHBack-SfiI anneals to VHHs N-terminal consensus sequences. Primers Lamb7-NotI and Lamb8-NotI hybridize to part of the short and long hinge region of the CH2 domain, respectively [44]. Their sequences are: VH1Back-SfiI: GCT GGA TTG TTA TTA CTC GCG GCC CAG CCG GCC ATG GCC CAG GTS MAR CTG CAG SAG TCW GG; VH6Back-SfiI: GCT GGA TTG TTA TTA TCT GCG GCC CAG CCG GCC ATG GCC GAT GTG CAG CTG CAG GCG TCT GGR GGA GG; Lamb7-NotI: G ATG GTG ATG ATG ATG TGC GGC CGC GCT GGG GTC TTC GCT GTG GTG CG; Lamb8-NotI: G ATG GTG ATG ATG ATG TGC GGC CGC TGG TTG TGG TTT TGG TGT CTT GGG. Restriction enzyme sequences are underlined. The resulting PCR fragments (approximately450 bp) were purified from agarose gels (GFX PCR DNA & Gel band purification Kit, Pharmacia), digested sequentially with SfiI and NotI and repurified.
###end p 70
###begin p 71
###xml 286 290 276 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Griffiths1">[45]</xref>
###xml 605 606 573 574 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 711 718 675 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 711 718 <span type="species:ncbi:562">E. coli</span>
For phage-display library construction, 5 microg of SfiI-NotI-digested plasmid pHEN2 and digested fragment were ligated in a 1:5 ratio during 16 hs at 16degreesC. Inserts were introduced between PelB leader signal and His-tag, in frame with pIII capsid protein gene in the vector pHEN2 [45]. The ligation reaction (200 microl) was purified with phenol:chloroform:isoamylic alcohol 25:24:1, extracted twice with chloroform and precipitated with 20 microg glycogen, 30 microl 2 M AcONa pH 5.2 and 440 microl EtOH for 24 hs at -80degreesC. The pellet was washed with 70% EtOH, dried, resuspended in 2 ml of H2O and concentrated with a centricon YM-3 (Amicon) to 15 microl in sterile milliQ water. Electrocompetent E. coli XL Blue MRFcells were transformed and library size was calculated by plating aliquots on LB ampicillin agar. The library diversity was checked by sequencing.
###end p 71
###begin title 72
Phage display
###end title 72
###begin p 73
###xml 118 123 118 123 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">600nm</sub>
###xml 665 673 647 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. cruzi</italic>
###xml 1036 1038 1000 1002 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sup>
###xml 1509 1516 1473 1480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003524-t001">Table 1</xref>
###xml 665 673 <span type="species:ncbi:5693">T. cruzi</span>
###xml 802 808 <span type="species:ncbi:9986">rabbit</span>
To prepare polyclonal phages, library stock or cells pre-infected with phages eluted during panning were grown until A600nm 0.5 and were then infected with at least 10-fold excess of VCS helper phage (Promega) at 37degreesC in presence of glucose 1%. After one hour incubation, cells were washed by harvesting and resuspending the cells in glucose-free fresh culture media. After growing over night at 30degreesC, phages were recovered from culture supernatant by incubation at 4degreesC followed of precipitation in 4% PEG 8,000, 0.5 M NaCl. Pellet was resuspended in 1 ml sterile PBS/100 ml culture and used for panning. To enrich the library for the presence of T. cruzi trans-sialidase binders, panning was performed on 24 well culture plates (Hamilton). Wells were coated with 2 microg polyclonal rabbit anti-SAPA antibody for 16 hs at 4degreesC. After blocking with 3% skim milk in PBS (SM-PBS), 10 microg TcTSDelta1443-SAPA were added in 1% SM-PBS with agitation during 2 hs followed by a similar incubation with approximately 1013 VHH-phages. Washing was done 3 times with PBS between each step. VHH-phage binders were eluted by incubation with 100 mM glycine-HCl pH 2.2 during 10 min and immediately neutralized with 2 M Tris-HCl pH 8.0. This procedure was followed by amplification of the eluted phages and repeated 2 times. Phage titers of input and output at all steps were estimated by enumeration of ampicillin resistant colonies obtained from TG1 cells infected with different phage dilutions (Table 1).
###end p 73
###begin p 74
###xml 341 348 341 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003524-t001">Table 1</xref>
To evaluate the enrichment during panning cycles, the capacity to bind TcTS of randomly chosen clones from each round was tested by phage-ELISA. Wells without immobilized protein were used as non-specific binding control (NSB). Unexpectedly, the proportion of binders decreased during successive rounds of panning due to negative selection (Table 1). Given this fact, we decided to work with phages from the first round of panning.
###end p 74
###begin title 75
Production of individual VHH-phages
###end title 75
###begin p 76
Plates with individual clones in culture medium with glucose were grown 3 hs at 37degreesC with agitation, and super infected with VCS helper phage for 30 min. Cells were pelleted, resuspended in the same medium without glucose and incubated for 16 hs at 30degreesC. The supernatants containing the VHH-phages were used for ELISA or TIA assays.
###end p 76
###begin title 77
Elisa
###end title 77
###begin p 78
###xml 482 483 478 479 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 485 486 481 482 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 492 497 488 493 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">495nm</sub>
###xml 67 73 <span type="species:ncbi:9986">rabbit</span>
###xml 354 359 <span type="species:ncbi:10090">mouse</span>
Plates were sensibilized over night with 200 ng/well of polyclonal rabbit anti-SAPA antibody. After blocking with 3% SM-PBS, 250 ng TcTSDelta1443-SAPA were added in 1% SM-PBS during 2 hs. Culture supernatant containing phages expressing VHHs were diluted twofold in 2% SM-PBS and added for 2 hs. Bound phages were washed with PBS-Tween and revealed with mouse anti-M13 conjugated to HRP (Pharmacia) dilution 1/2,000. Substrate (OPD, Sigma) was added, reaction was stopped with 2 M H2SO4 and A495nm was measured on an ELISA reader (Sigma960 Metertech Inc.).
###end p 78
###begin title 79
Production and purification of soluble VHHs
###end title 79
###begin p 80
###xml 71 78 71 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 71 78 <span type="species:ncbi:562">E. coli</span>
Phagemid DNAs recovered from six isolated clones were transformed into E. coli HB2151 cells. These cells are unable to suppress the amber stop codon between the cloned VHH and gene III, producing soluble VHH fragments tagged with C-terminal 6xHis upon induction with IPTG. After 4 hs induction with 1 mM IPTG, the expressed proteins were extracted from the periplasmic space through osmotic shock passing from 500 mM to 125 mM sucrose solution in buffer 200 mM Tris-HCl, 0.5 mM EDTA pH 8. The obtained VHHs have an apparent MW between 16,000 to 18,000 Da. Further purification of soluble protein was achieved on Hi-Trap chelating HP column (Pharmacia). Column was washed with 10 mM imidazole (Sigma) 0.3 M NaCl in sodium phosphate pH 8.0 and elution was done using 250 mM imidazole in the same buffer.
###end p 80
###begin title 81
Trans-sialidase activity assay
###end title 81
###begin p 82
###xml 140 142 132 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
Trans-sialidase activity was measured as the transfer of sialic acid from 1 mM sialyl-alpha-(2-3)-lactose (Sigma) to 12 microM [D-glucose-1-14C] lactose (55 mCi/mmol) (Amersham), by 0.5 ng of purified TcTS enzyme in 30 microl of 20 mM Hepes-Na (pH 7.5), 0.2% BSA, 30 mM NaCl. After 60 min at 25degreesC, the reaction was stopped by dilution with 1 ml of water. QAE-Sephadex (Amersham Pharmacia Biotech) was added and the resin was washed twice with water. Negative charged compounds were eluted with 0.8 ml of 1 M NaCl and quantified in a WinSpectral 1414 liquid scintillation counter (Wallac). When required, the purified enzyme was diluted in the reaction buffer before use (0.5 ng of TcTS611/2, rendered approximately4000 cpm per hour).
###end p 82
###begin title 83
Trans-sialidase Inhibition Assay (TIA)
###end title 83
###begin p 84
###xml 438 439 438 439 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 450 452 450 452 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 70 75 <span type="species:ncbi:9844">llama</span>
###xml 543 548 <span type="species:ncbi:9844">llama</span>
Culture supernatants from transformed HB2151 clones, purified phages, llama serum or purified VHHs, were assayed for their inhibitory activity on TcTS. Purified recombinant TcTS enzyme or TcTS derived from trypomastigotes (similar to the infective form of the parasite present in the mammalian host) were preincubated for 30 min with the sample to be tested, and the remnant ability to transfer the sialyl residues from sialyllactose to [d-glucose-1-14C] lactose was evaluated as described above. The different quantities used of each sample (llama serum, phage-VHHs or purified VHHs) are indicated in the corresponding figure. Results are expressed in percentage of inhibition of trans-sialidase activity. Reaction measured without addition of any inhibitor was considered as 0% of inhibition (100% of enzymatic activity).
###end p 84
###begin title 85
Dot spot assay
###end title 85
###begin p 86
###xml 93 102 93 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003524-g003">Figure 3C</xref>
###xml 306 311 <span type="species:ncbi:10090">mouse</span>
###xml 362 368 <span type="species:ncbi:9986">rabbit</span>
###xml 491 496 <span type="species:ncbi:10090">mouse</span>
###xml 500 506 <span type="species:ncbi:9986">rabbit</span>
###xml 507 518 <span type="species:ncbi:3704">horseradish</span>
Recombinant proteins (300 ng each) were spotted onto nitrocellulose membrane as indicated in Figure 3C. Filters were blocked for 2 hs with 5% SM-TBS, and when indicated, probed with a second purified protein for assessment of interactions. They were subsequently incubated with different antisera for 1 h (mouse anti-histidine serum (Sigma) at 1:500 dilution or rabbit anti-TcTS serum at 1:1,000 dilution) and washing 3 times with TBS after each treatment. Filters were processed using anti-mouse or rabbit horseradish peroxidase (HRP)-conjugated secondary antibodies (Gibco) at 1:8,000 dilution, and positive signals were revealed by chemiluminescence (Super Signal West Pico Chemiluminescent, Pierce).
###end p 86
###begin title 87
Affinity measurements
###end title 87
###begin p 88
Kinetic analyses of the interactions were determined with IAsys Biosensor instrument (ThermoLabSystems). Each purified monoclonal VHH was immobilized in 10 mM sodium acetate pH 5.0 on a carboxymethylated dextrane layer using EDC/NHS chemistry following the manufacture instructions. 10-30 ng of VHH were immobilized. For kinetic constant determination, dilutions of TcTS in PBS-0.05% Tween were added to the cuvette. Binding traces were recorded for at least 7 different concentrations. Measurements in present of DANA were done adding DANA to the cuvette before TcTS. The addition of DANA does not induce any change in the signal. Association and dissociation rate constants were calculated using the FASTFIT software.
###end p 88
###begin title 89
Immunoprecipitation of natural TcTS
###end title 89
###begin p 90
###xml 22 23 22 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 110 114 <span type="species:ncbi:10090">mice</span>
Crude extracts of 2x108 Cl-Brener trypomastigotes were incubated with purified anti-SAPA antibodies raised in mice (8 microg, ON, 4degreesC) followed by protein A-Sepharosa beads (75 microl, 4 hs, 4degreesC, Sigma). Beads were washed and conserved in Tris-HCl 20 mM, pH 7.6.
###end p 90
###begin title 91
Deglycosylation of TcTS
###end title 91
###begin p 92
PNGase F eliminates the entire N-glycosylation trees from GlcNAc of asparagine residues. Immunoprecipitated TcTS was incubated for 48 hs, at 37degreesC, in presence of PNGaseF (Biolabs) or in absence as a control of possible activity losses. Natural TcTS, deglycosylated or not, were diluted to rendering between 2000-3000 CPM/h (100% of activity) and assayed by TIA.
###end p 92
###begin title 93
Cloning of Trypomastigote TcTSs
###end title 93
###begin p 94
###xml 173 180 173 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LAPTSTE</italic>
###xml 183 191 183 191 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GA ATT C</underline>
###xml 182 228 182 228 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">G<underline>GA ATT C</underline>GC TAG CCT GGC ACC CGG ATC GAG CCG A </named-content>
###xml 269 273 269 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGA:</italic>
###xml 278 285 278 285 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAA TTC</underline>
###xml 273 320 273 320 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene"> GTG <underline>GAA TTC</underline> AGG CAC TCG TGT CGC TGC TGC TGT C </named-content>
###xml 371 379 371 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3&#8242; SAPA:</italic>
###xml 379 406 379 406 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene"> CAG CAG CAA AGC ACC CGC AC</named-content>
###xml 678 682 666 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Cremona1">[16]</xref>
cDNA or Genomic DNA from CL-Brener trypomastigotes were amplified by PCR using primers designed to amplify the entire globular core of TcTS gene family. Their sequences are LAPTSTE: GGA ATT CGC TAG CCT GGC ACC CGG ATC GAG CCG A (carrying EcoRI-NheI restriction sites), TGA: GTG GAA TTC AGG CAC TCG TGT CGC TGC TGC TGT C (carrying EcoRI restriction site) or alternatively 3' SAPA: CAG CAG CAA AGC ACC CGC AC. The PCR product, containing the intrinsic variability of TcTS family, render a single band (approximately2000 bp), which was cloned in pGEM-T Easy vector system (Promega) to further sequencing and selection of putative active TcTS (criteria based on presence of Tyr342) [16]. Individual chosen clones were subcloned in pTrcHisA (Invitrogen) using NheI-EcoRI restriction sites. TcTs were induced and purified as described above. The activity was assayed, linear condition of each TcTS clone concentration was confirmed before inhibition assay take place.
###end p 94
###begin p 95
###xml 146 154 146 154 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DQ315483</underline>
###xml 158 166 158 166 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DQ315486</underline>
###xml 192 200 192 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. cruzi</italic>
###xml 282 289 282 289 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EU80579</underline>
###xml 294 301 294 301 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">805801.</underline>
###xml 192 200 <span type="species:ncbi:5693">T. cruzi</span>
Data Bank accession codes- Sequences of the four TcTS strong inhibitor VHH clones have been deposited in the GenBank, with accession numbers from DQ315483 to DQ315486. Active TcTS clones from T. cruzi Cl-Brener strain have been deposited in the GenBank, with accession numbers from EU805797 to 805801.
###end p 95
###begin title 96
Supporting Information
###end title 96
###begin p 97
###xml 74 82 74 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. cruzi</italic>
###xml 74 82 <span type="species:ncbi:5693">T. cruzi</span>
Identity index between amino acid sequences of different TcTS clones from T. cruzi CL-Brener strain
###end p 97
###begin p 98
(0.11 MB DOC)
###end p 98
###begin p 99
Click here for additional data file.
###end p 99
###begin p 100
###xml 190 197 <span type="species:ncbi:3847">soybean</span>
###xml 304 309 <span type="species:ncbi:10090">mouse</span>
###xml 735 740 <span type="species:ncbi:10090">mouse</span>
Deglycosylation of immunoprecipitated natural TcTS with PNGasa F under non-denatured conditions. (A) Coomasie blue stained SDS-PAGE. The two left lanes show the results of SBA glycoprotein (soybean agglutinin) used as a control of PNGasa F activity. In the right lanes, heavy chain (hc) corresponding to mouse anti-SAPA used to immunoprecipitate natural TcTS population from trypomastigotes, present in the same sample used in experiment indicated in panel B, that showed a lower molecular weight after treatment with PNGasa F. Due to the low amount of immunoprecipitated protein, TcTS was not detectable in coomasie blue stained gel. Panel (B) shows a Western blot of immunoprecipitated TcTS, incubated with anti-SAPA serum raised in mouse and revealed with the corresponding HRP-conjugated-anti-serum for chemiluminescence generation. The arrow is to indicate the TcTS band with a stronger signal (TcTS display several bands in Western blot) and that has an apparent lower molecular weight after PNGase F treatment. (+) indicates incubation with PNGase F and (-) indicates incubation in the absence of PNGase F.
###end p 100
###begin p 101
(3.18 MB TIF)
###end p 101
###begin p 102
Click here for additional data file.
###end p 102
###begin p 103
###xml 97 105 97 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. cruzi</italic>
###xml 227 231 227 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003524-Pollevick1">[47]</xref>
###xml 97 105 <span type="species:ncbi:5693">T. cruzi</span>
Deduced amino acid sequences of entire globular core of TcTSs, without SAPA repeats, cloned from T. cruzi Cl-Brener strain. All sequences start with a leucine, that is the first amino acid residue in the mature natural protein [47]. Amino acidic residues differing to those present in TcTS611/2 clone are boxed. Asterisk indicates the putative N-glycosilation site near the active site, as predicted by NetNglyc 1.0 Server (). Alignment was performed by .
###end p 103
###begin p 104
(17.39 MB TIF)
###end p 104
###begin p 105
Click here for additional data file.
###end p 105
###begin p 106
###xml 82 88 <span type="species:ncbi:9844">llamas</span>
We are grateful to Gonzalo Perez Zabala and Guillermo Vila Melo for providing the llamas farm site and veterinarian care. We thank B. Cazzullo, L. Sferco and A. Chidichimo for their technical assistance with parasite and cell cultures, A. Meras and N. Neimellet for technical assistance with protein purification, O. Campetella and J. Mucci for TcTSDelta1443-SAPA clone and advice, S. Leguizamon for giving us supernatant to Villegas strain and J. DeGaudenzi for help with the TcTS cloning.
###end p 106
###begin title 107
References
###end title 107
###begin article-title 108
Parasite immune escape: new views into host-parasite interactions.
###end article-title 108
###begin article-title 109
The trypanosomiases.
###end article-title 109
###begin article-title 110
###xml 0 17 0 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trypanosoma cruzi</italic>
###xml 0 17 <span type="species:ncbi:5693">Trypanosoma cruzi</span>
Trypanosoma cruzi surface mucins: host-dependent coat diversity.
###end article-title 110
###begin article-title 111
###xml 40 57 40 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trypanosoma cruzi</italic>
###xml 40 57 <span type="species:ncbi:5693">Trypanosoma cruzi</span>
A novel cell surface trans-sialidase of Trypanosoma cruzi generates a stage-specific epitope required for invasion of mammalian cells.
###end article-title 111
###begin article-title 112
###xml 13 38 13 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trypanosoma brucei brucei</italic>
###xml 13 38 <span type="species:ncbi:5702">Trypanosoma brucei brucei</span>
###xml 42 47 <span type="species:ncbi:9606">human</span>
The lysis of Trypanosoma brucei brucei by human serum.
###end article-title 112
###begin article-title 113
###xml 66 84 66 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trypanosoma cruzi.</italic>
###xml 66 83 <span type="species:ncbi:5693">Trypanosoma cruzi</span>
Functional diversity in the trans-sialidase and mucin families in Trypanosoma cruzi.
###end article-title 113
###begin article-title 114
###xml 59 78 59 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trypanosoma rangeli</italic>
###xml 59 78 <span type="species:ncbi:5698">Trypanosoma rangeli</span>
###xml 113 121 <span type="species:ncbi:5693">T. cruzi</span>
The high resolution structures of free and inhibitor-bound Trypanosoma rangeli sialidase and its comparison with T. cruzi trans-sialidase.
###end article-title 114
###begin article-title 115
###xml 77 94 77 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trypanosoma cruzi</italic>
###xml 77 94 <span type="species:ncbi:5693">Trypanosoma cruzi</span>
The crystal structure and mode of action of trans-sialidase, a key enzyme in Trypanosoma cruzi pathogenesis.
###end article-title 115
###begin article-title 116
Structural basis of sialyltransferase activity in trypanosomal sialidases.
###end article-title 116
###begin article-title 117
A sialidase mutant displaying trans-sialidase activity.
###end article-title 117
###begin article-title 118
###xml 70 87 70 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trypanosoma cruzi</italic>
###xml 70 87 <span type="species:ncbi:5693">Trypanosoma cruzi</span>
Trans-sialidase, SAPA amino acid repeats and the relationship between Trypanosoma cruzi and the mammalian host.
###end article-title 118
###begin article-title 119
###xml 31 48 31 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trypanosoma cruzi</italic>
###xml 31 48 <span type="species:ncbi:5693">Trypanosoma cruzi</span>
Tandem amino acid repeats from Trypanosoma cruzi shed antigens increase the half-life of proteins in blood.
###end article-title 119
###begin article-title 120
###xml 25 42 25 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trypanosoma cruzi</italic>
###xml 25 42 <span type="species:ncbi:5693">Trypanosoma cruzi</span>
The repetitive domain of Trypanosoma cruzi trans-sialidase enhances the immune response against the catalytic domain.
###end article-title 120
###begin article-title 121
###xml 20 31 20 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trypanosoma</italic>
###xml 20 37 <span type="species:ncbi:5693">Trypanosoma cruzi</span>
Identification of a Trypanosoma cruzi antigen that is shed during the acute phase of Chagas' disease.
###end article-title 121
###begin article-title 122
###xml 22 39 22 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trypanosoma cruzi</italic>
###xml 22 39 <span type="species:ncbi:5693">Trypanosoma cruzi</span>
###xml 78 83 <span type="species:ncbi:9606">human</span>
Antibodies inhibiting Trypanosoma cruzi trans-sialidase activity in sera from human infections.
###end article-title 122
###begin article-title 123
###xml 64 81 64 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trypanosoma cruzi</italic>
###xml 64 81 <span type="species:ncbi:5693">Trypanosoma cruzi</span>
Enzymically inactive members of the trans-sialidase family from Trypanosoma cruzi display beta-galactose binding activity.
###end article-title 123
###begin article-title 124
###xml 40 51 40 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trypanosoma</italic>
Structural and functional properties of Trypanosoma trans-sialidase.
###end article-title 124
###begin article-title 125
###xml 23 40 23 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trypanosoma cruzi</italic>
###xml 23 40 <span type="species:ncbi:5693">Trypanosoma cruzi</span>
Thymocyte depletion in Trypanosoma cruzi infection is mediated by trans-sialidase-induced apoptosis on nurse cells complex.
###end article-title 125
###begin article-title 126
###xml 21 38 21 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trypanosoma cruzi</italic>
###xml 21 38 <span type="species:ncbi:5693">Trypanosoma cruzi</span>
Trans-sialidase from Trypanosoma cruzi catalyzes sialoside hydrolysis with retention of configuration.
###end article-title 126
###begin article-title 127
###xml 38 55 38 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trypanosoma cruzi</italic>
###xml 38 55 <span type="species:ncbi:5693">Trypanosoma cruzi</span>
Lactose derivatives are inhibitors of Trypanosoma cruzi trans-sialidase activity toward conventional substrates in vitro and in vivo.
###end article-title 127
###begin article-title 128
###xml 25 42 25 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trypanosoma cruzi</italic>
###xml 25 42 <span type="species:ncbi:5693">Trypanosoma cruzi</span>
The trans-sialidase from Trypanosoma cruzi triggers apoptosis by target cell sialylation.
###end article-title 128
###begin article-title 129
###xml 19 36 19 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trypanosoma cruzi</italic>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 19 36 <span type="species:ncbi:5693">Trypanosoma cruzi</span>
Mice infected with Trypanosoma cruzi produce antibodies against the enzymatic domain of trans-sialidase that inhibit its activity.
###end article-title 129
###begin article-title 130
###xml 62 79 62 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trypanosoma cruzi</italic>
###xml 27 35 <span type="species:ncbi:9606">patients</span>
###xml 62 79 <span type="species:ncbi:5693">Trypanosoma cruzi</span>
Sera from chronic Chagasic patients and rodents infected with Trypanosoma cruzi inhibit trans-sialidase by recognizing its amino-terminal and catalytic domain.
###end article-title 130
###begin article-title 131
###xml 128 136 <span type="species:ncbi:9606">patients</span>
Long-lasting antibodies detected by a trans-sialidase inhibition assay of sera from parasite-free, serologically cured chagasic patients.
###end article-title 131
###begin article-title 132
###xml 25 42 25 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trypanosoma cruzi</italic>
###xml 25 42 <span type="species:ncbi:5693">Trypanosoma cruzi</span>
The trans-sialidase from Trypanosoma cruzi induces thrombocytopenia during acute Chagas' disease by reducing the platelet sialic acid contents.
###end article-title 132
###begin article-title 133
###xml 38 47 <span type="species:ncbi:9838">dromedary</span>
Potent enzyme inhibitors derived from dromedary heavy-chain antibodies.
###end article-title 133
###begin article-title 134
Naturally occurring antibodies devoid of light chains.
###end article-title 134
###begin article-title 135
###xml 0 5 <span type="species:ncbi:9838">Camel</span>
Camel single-domain antibody inhibits enzyme by mimicking carbohydrate substrate.
###end article-title 135
###begin article-title 136
###xml 40 57 40 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trypanosoma cruzi</italic>
###xml 40 57 <span type="species:ncbi:5693">Trypanosoma cruzi</span>
Epitope mapping of trans-sialidase from Trypanosoma cruzi reveals the presence of several cross-reactive determinants.
###end article-title 136
###begin article-title 137
###xml 116 133 116 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trypanosoma cruzi</italic>
###xml 116 133 <span type="species:ncbi:5693">Trypanosoma cruzi</span>
A functional network of intramolecular cross-reacting epitopes delays the elicitation of neutralizing antibodies to Trypanosoma cruzi trans-sialidase.
###end article-title 137
###begin article-title 138
###xml 0 19 0 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trypanosoma rangeli</italic>
###xml 0 19 <span type="species:ncbi:5698">Trypanosoma rangeli</span>
###xml 69 77 <span type="species:ncbi:5693">T. cruzi</span>
Trypanosoma rangeli sialidase: cloning, expression and similarity to T. cruzi trans-sialidase.
###end article-title 138
###begin article-title 139
Probing molecular function of trypanosomal sialidases: single point mutations can change substrate specificity and increase hydrolytic activity.
###end article-title 139
###begin article-title 140
###xml 52 69 52 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trypanosoma cruzi</italic>
###xml 52 69 <span type="species:ncbi:5693">Trypanosoma cruzi</span>
Structural insights into the catalytic mechanism of Trypanosoma cruzi trans-sialidase.
###end article-title 140
###begin article-title 141
Association between serum sialic acid concentration and carotid atherosclerosis measured by B-mode ultrasound. The ARIC Investigators. Atherosclerosis Risk in Communities Study.
###end article-title 141
###begin article-title 142
Multiple display of a protein domain on a bacterial polymeric scaffold.
###end article-title 142
###begin article-title 143
###xml 0 16 <span type="species:ncbi:562">Escherichia coli</span>
###xml 38 43 <span type="species:ncbi:9844">llama</span>
Escherichia coli F4 fimbriae specific llama single-domain antibody fragments effectively inhibit bacterial adhesion in vitro but poorly protect against diarrhoea.
###end article-title 143
###begin article-title 144
Beta-lactamase inhibitors derived from single-domain antibody fragments elicited in the camelidae.
###end article-title 144
###begin article-title 145
Three camelid VHH domains in complex with porcine pancreatic alpha-amylase. Inhibition and versatility of binding topology.
###end article-title 145
###begin article-title 146
###xml 4 21 4 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trypanosoma cruzi</italic>
###xml 4 21 <span type="species:ncbi:5693">Trypanosoma cruzi</span>
The Trypanosoma cruzi proteome.
###end article-title 146
###begin article-title 147
###xml 94 111 94 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trypanosoma cruzi</italic>
###xml 71 75 <span type="species:ncbi:10090">mice</span>
###xml 94 111 <span type="species:ncbi:5693">Trypanosoma cruzi</span>
Immunization with an engineered mutant trans-sialidase highly protects mice from experimental Trypanosoma cruzi infection: a vaccine candidate.
###end article-title 147
###begin article-title 148
###xml 129 146 129 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trypanosoma cruzi</italic>
###xml 129 146 <span type="species:ncbi:5693">Trypanosoma cruzi</span>
Trans-sialidase recombinant protein mixed with CpG motif-containing oligodeoxynucleotide induces protective mucosal and systemic Trypanosoma cruzi immunity involving CD8+ CTL and B cell-mediated cross-priming.
###end article-title 148
###begin article-title 149
###xml 29 46 29 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trypanosoma cruzi</italic>
###xml 29 46 <span type="species:ncbi:5693">Trypanosoma cruzi</span>
Immune system recognition of Trypanosoma cruzi.
###end article-title 149
###begin article-title 150
###xml 28 45 28 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trypanosoma cruzi</italic>
###xml 28 45 <span type="species:ncbi:5693">Trypanosoma cruzi</span>
###xml 80 85 <span type="species:ncbi:10090">mouse</span>
Protective immunity against Trypanosoma cruzi infection in a highly susceptible mouse strain after vaccination with genes encoding the amastigote surface protein-2 and trans-sialidase.
###end article-title 150
###begin article-title 151
###xml 61 66 <span type="species:ncbi:9838">camel</span>
Sequence and structure of VH domain from naturally occurring camel heavy chain immunoglobulins lacking light chains.
###end article-title 151
###begin article-title 152
###xml 27 32 <span type="species:ncbi:9606">human</span>
Isolation of high affinity human antibodies directly from large synthetic repertoires.
###end article-title 152
###begin article-title 153
IMGT, the international ImMunoGeneTics database.
###end article-title 153
###begin article-title 154
Members of the SAPA/trans-sialidase protein family have identical N-terminal sequences and a putative signal peptide.
###end article-title 154
###begin p 155
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 155
###begin p 156
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by grants from the National Institutes of Health, grant AI060645-01 to ACF, Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) and the Consejo Nacional de Investigaciones Cientificas y Tecnicas. The work of ACF and FAG was partially supported by International Research Scholar grants from the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 156

